Lista de obras -

4th National Conference of the Italian Association of Medical Oncology. From research to clinical practice: the role of topotecan in oncology

artículo científico publicado en 2002

A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer

artículo científico publicado en 2019

AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer

artículo científico publicado en 2004

ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms

artículo científico publicado en 2005

ASCO 2008. Bevacizumab in advanced renal carcinoma

artículo científico publicado en 2008

ASCO Annual Meeting 2004, New Orleans. Capecitabine in adjuvant therapy of colorectal carcinoma: first... the evidence

artículo científico publicado en 2004

ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma

artículo científico publicado en 2004

ASCO Annual Meeting 2004, New Orleans. Therapeutic options in colorectal cancer

artículo científico publicado en 2004

ASCO Annual Meeting 2004, New Orleans. Tumoral angiogenesis and inhibition of VEGF: clinical implications

artículo científico publicado en 2004

Analysis of CT features and quantitative texture analysis in patients with thymic tumors: correlation with grading and staging.

artículo científico publicado en 2018

Bevacizumab in the treatment of colorectal carcinoma: news from ASCO 2008

artículo científico publicado en 2008

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

artículo científico publicado en 2012

Breast Cancer Conference. Trastuzumab and capecitabine in the treatment of advanced breast cancer. Milano, 6-7 June 2002

artículo científico publicado en 2002

Capecitabine in elderly patients with metastatic breast cancer.

artículo científico publicado en 2012

Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting

artículo científico publicado en 2008

Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors

artículo científico publicado en 2015

Circulating tumor cells in high-risk nonmetastatic colorectal cancer

artículo científico publicado en 2013

Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens

artículo científico publicado en 2020

Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

artículo científico publicado en 2016

Development of a prediction model and risk score for procedure-related complications in patients undergoing percutaneous computed tomography-guided lung biopsy

artículo científico

Docetaxel and novel strategies in the treatment of NSCLC

artículo científico publicado en 2005

ESMO 2004. Nausea and vomiting caused by chemotherapy: improving the treatment

artículo científico publicado en 2005

ESMO Conference 2004. Ibandronate in the treatment of bone metastasis

artículo científico publicado en 2004

Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study

artículo científico publicado en 2017

Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial

artículo científico publicado en 2012

Endocrine therapy of causation: role of aromatase inhibitors in breast cancer

artículo científico publicado en 2003

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

artículo científico publicado en 2013

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

artículo científico publicado en 2012

Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers ⬇️

artículo científico publicado el 18 de junio de 2013

Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC.

artículo científico publicado en 2017

HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma ⬇️

artículo científico publicado el 20 de marzo de 2012

IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer

artículo científico publicado en 2017

Ibandronate: keep life in motion

artículo científico publicado en 2004

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey

artículo científico publicado en 2014

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

artículo científico publicado en 2015

Long-term outcome after multimodality treatment for stage III thymic tumors

artículo científico publicado en 2003

Merkel cell carcinoma of the retroperitoneum with no identifiable primary site.

artículo científico publicado en 2013

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

artículo científico publicado en 2013

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

artículo científico publicado en 2016

Multimodality treatment of stage II thymic tumours.

artículo científico publicado en 2017

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

artículo científico publicado en 2015

New prospects in the treatment of advanced colorectal tumors. Barcelona, June 20-22, 2002

artículo científico publicado en 2002

News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors

artículo científico publicado en 2007

Oral capecitabine therapy: experience and developments at the Milano Cancer Institute

artículo científico publicado en 2004

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.

artículo científico publicado en 2010

Preliminary clinical experience with a dedicated interventional robotic system for CT-guided biopsies of lung lesions: a comparison with the conventional manual technique.

artículo científico publicado en 2014

Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor recep

artículo científico publicado en 2011

Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer

artículo científico publicado en 2016

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer ⬇️

artículo científico publicado el 13 de abril de 2012

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)

artículo científico publicado en 2015

Toward the cure of "early-stage" solid tumors: the role of docetaxel

artículo científico publicado en 2005

Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience

artículo científico publicado en 2011

[AIOM 2008. Neuroendocrine tumors and clinical practice]

artículo científico publicado en 2008

[ASCO 2003--What is changing in the treatment of colorectal cancer]

artículo científico publicado en 2003

[ASCO 2008. Therapy of breast carcinoma in a neoadjuvant, adjuvant and metatstatic setting]

artículo científico publicado en 2008

[Advances in the treatment of metastatic colorectal cancer with bevacizumab]

artículo científico publicado en 2006

[Bevacizumab combined with chemotherapy in the treatment of solid tumors: the novelty from ASCO 2005]

artículo científico publicado en 2005

[Capecitabine in colorectal carcinoma: news from ASCO 2008]].

artículo científico publicado en 2008

[ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting]

artículo científico publicado en 2006

[ESMO 2004. Comparative studies delineating future options in the treatment of solid tumors].

artículo científico publicado en 2005

[How is the treatment changing in metastatic carcinoma of the colorectum]

artículo científico publicado en 2007

[Novel methods of treatment for colorectal carcinoma: from oral chemotherapy to angiogenesis inhibitors]

artículo científico publicado en 2006

[Renal carcinoma update and prospectives]

scientific article published on 01 January 2008

Lista de obras de

4th National Conference of the Italian Association of Medical Oncology. From research to clinical practice: the role of topotecan in oncology

A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer

AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer

ASCO 2005: Progression with oxaliplatin in the treatment of colorectal neoplasms

ASCO 2008. Bevacizumab in advanced renal carcinoma

ASCO Annual Meeting 2004, New Orleans. Capecitabine in adjuvant therapy of colorectal carcinoma: first... the evidence

ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma

ASCO Annual Meeting 2004, New Orleans. Therapeutic options in colorectal cancer

ASCO Annual Meeting 2004, New Orleans. Tumoral angiogenesis and inhibition of VEGF: clinical implications

Analysis of CT features and quantitative texture analysis in patients with thymic tumors: correlation with grading and staging.

Bevacizumab in the treatment of colorectal carcinoma: news from ASCO 2008

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

Breast Cancer Conference. Trastuzumab and capecitabine in the treatment of advanced breast cancer. Milano, 6-7 June 2002

Capecitabine in elderly patients with metastatic breast cancer.

Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting

Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors

Circulating tumor cells in high-risk nonmetastatic colorectal cancer

Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens

Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

Development of a prediction model and risk score for procedure-related complications in patients undergoing percutaneous computed tomography-guided lung biopsy

Docetaxel and novel strategies in the treatment of NSCLC

ESMO 2004. Nausea and vomiting caused by chemotherapy: improving the treatment

ESMO Conference 2004. Ibandronate in the treatment of bone metastasis

Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study

Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial

Endocrine therapy of causation: role of aromatase inhibitors in breast cancer

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers ⬇️

Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC.

HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma ⬇️

IL-18 receptor marks functional CD8+ T cells in non-small cell lung cancer

Ibandronate: keep life in motion

Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

Long-term outcome after multimodality treatment for stage III thymic tumors

Merkel cell carcinoma of the retroperitoneum with no identifiable primary site.

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

Multimodality treatment of stage II thymic tumours.

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

New prospects in the treatment of advanced colorectal tumors. Barcelona, June 20-22, 2002

News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors

Oral capecitabine therapy: experience and developments at the Milano Cancer Institute

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Preliminary clinical experience with a dedicated interventional robotic system for CT-guided biopsies of lung lesions: a comparison with the conventional manual technique.

Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor recep

Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer ⬇️

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)

Toward the cure of "early-stage" solid tumors: the role of docetaxel

Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience

[AIOM 2008. Neuroendocrine tumors and clinical practice]

[ASCO 2003--What is changing in the treatment of colorectal cancer]

[ASCO 2008. Therapy of breast carcinoma in a neoadjuvant, adjuvant and metatstatic setting]

[Advances in the treatment of metastatic colorectal cancer with bevacizumab]

[Bevacizumab combined with chemotherapy in the treatment of solid tumors: the novelty from ASCO 2005]

[Capecitabine in colorectal carcinoma: news from ASCO 2008]].

[ECCO 2005. Advances in the prevention of chemotherapy-induced nausea and vomiting]

[ESMO 2004. Comparative studies delineating future options in the treatment of solid tumors].

[How is the treatment changing in metastatic carcinoma of the colorectum]

[Novel methods of treatment for colorectal carcinoma: from oral chemotherapy to angiogenesis inhibitors]

[Renal carcinoma update and prospectives]